Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.19.00320
Abstract: PURPOSE Immune checkpoint inhibitor (ICI) therapy often is suspended because of immune-mediated diarrhea and colitis (IMDC). We examined the rate of and risk factors for IMDC recurrence after ICI resumption. METHODS This retrospective multicenter study… read more here.
Keywords: therapy; resumption; imdc; immune checkpoint ... See more keywords